What are your hopes for 2021?
Like the rest of the country, get my vaccination and help stop the spread of COVID so we can get some normality back into all our lives!
But beyond that I would like to grow and scale Kinomica and move our KScan technology into clinical trials and clinical practise so that patients can start to benefit from this disruptive technology.
One prediction for this year?
That diagnostics and data science in particular will be our route out of many of the challenges we face. As a nation facing COVID, diagnostics and the resultant data should be at the heart of what we do and why we do it. Data equals insights and insights mean that the appropriate decisions can be taken.
It is the same for Kinomica in the Pharma industry. KScan cell signalling profiling gives unprecedented insights that can't be achieved using conventional "one at a time" antibody techniques. Our datasets and the resultant insights are highly disruptive and should change how we go about drug discovery, development, and diagnosis of disease.
What do "we" as an industry need to do more of?
We as a life sciences industry need to collaborate, communicate, and create powerful datasets that lead to insights that improve patients' lives. Our best chance of doing this lies in building diverse teams with a strong support network. In diversity, you have real strength. I can only point to the Kinomica team and our external supporters and cheer leaders, we have around us. I am incredibly proud to say I think we have a very diverse and incredibly strong team as a result, supported by an incredible ecosystem in our industry.